Friends! In this video, I'm going to do an AMD stock analysis and talk about the risks and upside potential of AMD stock
1 extracted signal · 1 resolved · 0 still active
The Patient Investor05 Aug 2025, 21:47 UTC
AI-generated source summary
The analysis is based on AMD's Q2 2025 financial results. Earnings per share missed estimates at 48 cents adjusted versus 49 cents expected. Revenue beat expectations at $7.69 billion versus $7.42 billion expected. Guidance for the third quarter is strong, expecting sales of $8.7 billion plus or minus $300 million, versus analyst expectations of $8.3 billion. Revenue growth was 32% year-on-year. Non-GAAP gross margins decreased from 53% to 43%. Operating income and earnings per share on a non-GAAP basis also declined year-on-year. The data center business revenue was weak but client and gaming segments showed 69% overall growth. Chip export restrictions to China had a negative impact of $800 million in the June quarter. The speaker said shipments expected to resume waivers potentially being approved. The guidance does not include China revenues. The speaker provided a valuation model with an earnings per share of $3.96 for 2025, 48% growth for 2026 and 20% from 2027 to 2030 with a PE ratio of 30 times implying a $364.59 target.
AI-generated summary based on the source content.
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
Signals in this source
More Prediction Case Files from The Patient Investor
Why I Don't Own Google Stock & When I'm Buying
The CHEAPEST Quality Stock In The Stock Market!
Intuitive Surgical Stock Analysis! Risks & Upside Potential
There Is NO AI BUBBLE! I’m Buying Every Dip
2 Stocks I'm Buying In The Next 2 Weeks
Netflix Stock Is FINALLY A Buy!
The Patient Investor
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
